The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study

PURPOSE: This nonrandomized study aimed to evaluate body weight and composition during the menstrual cycle and during oral contraception with 30 microg of ethinylestradiol plus 3 mg of drospirenone (EE+DRSP). DESIGN: Multifrequency bioelectrical impedance analysis was carried out in 38 normally cycling women (mean age, 25.5 years) at baseline during the follicular phase (FP) and the luteal phase (LP) of the menstrual cycle and after three and six cycles of EE+DRSP to evaluate total body water (TBW), intracellular water (ICW), extracellular water (ECW), fat mass and fat-free mass. Body weight, waist-to-hip ratio, blood pressure and the plasma concentrations of electrolytes were also determined at each visit. RESULTS: TBW and ECW increased in the LP. During EE+DRSP, TBW and ECW were significantly lower than in the LP but similar to the values measured in the FP. No significant variations in ICW or in the other parameters were observed. CONCLUSION: EE+DRSP maintains the same concentrations in TBW and ECW observed in the FP. This effect is likely due to the antimineralocorticoid activity of DRSP, which counteracts the water retention elicited by estrogen.     

Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass

Background

We aimed to evaluate whether a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol (EE2) plus 2 mg of chlormadinone acetate (CMA) (EE2+CMA) alters body weight (BW) and body composition of healthy young women with normal menstrual cycles. The results in treated subjects were compared to those obtained in nontreated women as control.

Study Design

Multifrequency bioelectrical impedance analysis (MF-BIA) was performed in 48 healthy young women during the follicular phase of their menstrual cycle. Of this group, 24 women were treated with EE2+CMA, and the MF-BIA was repeated at the third and sixth cycle of treatment. The remaining 24 women were submitted to the same examinations after three and six cycles without any treatment. Total body water (TBW), intracellular water (ICW), extracellular water (ECW), fat mass (FM) and fat-free mass (FFM) were calculated. Waist-to-hip ratio (WHR), BW, blood pressure, and the plasma concentrations of electrolytes were also measured at each visit.

Results

Mean FM significantly (p<.05) decreased in the EE2+CMA group from basal levels of 14.23±1.03 to 13.51±1.09 and 12.71±1.02 kg at the third and sixth cycle of treatment, respectively. Stable values were seen in the control group. During observation, other parameters (BW, WHR, TBW, ECW, ICW, FFM) remained unchanged in all subjects.

Conclusions

EE2+CMA reduces FM without altering TBW, ICW, ECW. These preliminary results suggest that progestational activity of CMA could balance both fluid retention and weight gain elicited by EE2.     

A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms

This open-label randomized study compared the effects of two combined oral contraceptives (OCs) containing 3 mg drospirenone (DRSP)/30 microg ethinyl estradiol (EE) with 150 microg levonorgestrel (LNG)/30 microg EE on the prevalence and changes from baseline of premenstrual symptoms after six cycles. The symptoms were measured using the Women's Health Assessment Questionnaire. Subjects receiving DRSP/EE had fewer prevalence of premenstrual symptoms than those receiving LNG/EE after six cycles. A significantly lower score of negative affect category in the premenstrual phase was demonstrated in those receiving DRSP/EE more than LNG/EE. The DRSP/EE group showed a greater improvement of mean scores from baseline in the premenstrual phase compared with those who received LNG/EE on negative affect as seen in the items on anxiety, irritability, feeling sad or blue and weight gain in the category of water retention. In conclusion, OCs containing DRSP have beneficial effects in reducing the prevalence of premenstrual symptoms especially the symptoms of negative affect and weight gain, particularly when compared to LNG/EE. Hence, it should be recommended for women who are susceptible to these adverse symptoms.     

Measurement of body water by multifrequency bioelectrical impedance spectroscopy in a multiethnic pediatric population.

BACKGROUND: Bioelectrical impedance spectroscopy (BIS) may provide a noninvasive, rapid method for the assessment of total body water (TBW), extracellular water (ECW), and intracellular water (ICW). Few studies, however, have examined the accuracy of BIS in pediatric populations. OBJECTIVE: Our objective was to evaluate the accuracy of BIS for the measurement of TBW, ECW, and ICW in healthy children. DESIGN: Dual-energy X-ray absorptiometry (DXA), total body potassium (TBK), and BIS measurements were performed in 347 children (202 males and 145 females aged 4-18 y). The reference values for TBW, ECW, and ICW were defined by using a DXA+TBK model. BIS values were evaluated by using the method of Bland and Altman. A randomly selected calibration group (n = 231) was used to derive new BIS constants that were tested in the remaining group (n = 116). RESULTS: BIS values were highly correlated with the reference values (r(2) = 0.94-0.97, P < 0.0001), but differences between the BIS and DXA+TBK models for individuals were significant (P < 0.001). Use of new BIS constants reduced the mean differences between the BIS and DXA+TBK models; the SDs of the mean differences were improved (1.8 L for TBW, 1.4 L for ICW, and 1.0 L for ECW) for the total population. CONCLUSIONS: On a population basis, BIS can be calibrated to replace the DXA+TBK model for the assessment of TBW, ECW, and ICW in healthy children. The accuracy of the BIS measurement in individual children may be refined further by using age- and sex-specific adjustments for the BIS calibration constants.     

Effects of Water Restriction and Water Replenishment on the Content of Body Water with Bioelectrical Impedance among Young Adults in Baoding,China: A Randomized Controlled Trial (RCT)

Insufficient water intake may affect body composition. The purpose of this research was to explore the effects of water restriction and replenishment on body composition and to evaluate the optimum amount of water that improves body composition. A total of 76 young adults aged 18–23 years old (40 males and 36 females) in Baoding, China, were recruited in this randomized controlled trial, with a 100% completion rate. After fasting overnight for 12 h, at 8:00 a.m. of day 2, a baseline test, including anthropometric indices and collection of urine and blood samples, was explored. Participants were then subjected to water restriction for 24 h, and three meals with ≤75% water content were provided. At 8:00 AM of day 3, the same indices were determined as a dehydration test. Then, participants were randomly assigned into four groups: three water replenishment groups (WR groups 1, 2, and 3 given 1000, 500, and 200 mL of purified water, respectively) and one non-replenishment group (NR group, with no water). After 90 min, the same measurements were performed as a rehydration test. Compared with the baseline test, during the dehydration test, the intracellular water to total body water ratio (ICW/TBW) increased; and extracellular water (ECW), ECW/TBW (extracellular water to total body water ratio), and TBW decreased (all p < 0.05). For males, significant differences were found in ECW, ECW/ICW (extracellular water to intracellular water ratio), ICW/TBW, and ECW/TBW (all p < 0.05); for females, significant reductions were found in ICW, ECW, TBW, ECW/ICW, ICW/TBW, and ECW/TBW (all p < 0.05). Furthermore, significant differences were found in ICW, ECW, ICW/TBW, ECW/TBW, ECW/ICW, TBW, and TBW/BW between males and females during the baseline and dehydration test (all p < 0.05). Comparing the dehydration test with the rehydration test, there were significant interactions between time × volume in ICW and TBW (F = 3.002, p = 0.036; F = 2.907, p = 0.040); in males, these were only found in ICW (F = 3.061, p = 0.040); in females, they were found in ICW and TBW (F = 3.002, p = 0.036; F = 2.907, p = 0.040). The ICW levels in WR groups 1 and 2 were all higher than in the NR group (all p < 0.05); the TBW was higher in WR group 1 than in the NR group (p < 0.05). No significant differences were found between WR groups 1 and 2, either in males or in females (all p > 0.05). In the rehydration test, significant differences in body composition were found between males and females among the four groups (all p < 0.05). Water restriction had adverse effects on body composition, and females were more susceptible to water restriction than males. Water replenishment improved the water content of body composition, alleviating the adverse effects of water restriction on ICW and TBW. After water restriction for 36 h, the optimum volume of water to improve body composition among young male adults was 1000 mL, but this was not the case for females.     

Effect of a moderately hypoenergetic Mediterranean diet and exercise program on body cell mass and cardiovascular risk factors in obese women

OBJECTIVE: To assess the effects of a moderately hypoenergetic Mediterranean diet (MHMD) and exercise program on body cell mass (BCM) and cardiovascular disease risk factors in obese women. SUBJECTS/METHODS: Forty-seven obese women, 39.7+/-13.2 years of age, with a body mass index (BMI)=30.7+/-6.0 kg/m(2), completed the study. The following were measured at baseline, 2 and 4 months: BCM, BCM index (BCMI), body weight, BMI, fat-free mass (FFM), fat mass (FM), total body water (TBW), extracellular water (ECW) and intracellular water (ICW) using bioelectrical impedance analysis; fasting blood glucose (FBG), serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) concentrations; systolic (SBP) and diastolic (DBP) blood pressure. RESULTS: Body weight, BMI, FM, TC and TG significantly decreased (P<0.001; P<0.002 (TG)) at 2 and 4 months. FFM, TBW, ECW, FBG and DBP significantly decreased at 2 months (P<0.05 (FFM); P<0.001). LDL-C significantly decreased (P<0.001), while HDL-C significantly increased (P<0.002) at 4 months. BCM, BCMI, ICW and SBP remained stable over time. CONCLUSION: BCM was preserved and cardiovascular disease risk factors improved in obese women placed on a MHMD and exercise program for 4 months.     

Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS). This is the first trial of a unique oral contraceptive containing a combination of drospirenone (DRSP, 3 mg) and ethinyl estradiol (EE, 30 microg) for the treatment of PMDD. DRSP is a spironolactone-like progestin with antiandrogenic and antimineralocorticoid activity. Spironolactone has been shown to be beneficial in PMS, whereas oral contraceptives have shown conflicting results. In this double-blind, placebo-controlled trial, 82 women with PMDD (Diagnostic and Statistical Manual of Mental Disorders, 4th ed. [DSM IV]) were randomized to receive DRSP/EE or placebo for three treatment cycles. The primary end point was change from baseline in luteal phase symptom scores as assessed on the Calendar of Premenstrual Experiences (COPE) scale. Patients treated with DRSP/EE showed a numerically greater change from baseline compared with those treated with placebo on each of the 22 COPE items and each of the 4 symptom factors. Between-group differences in symptom improvement reached statistical significance in factor 3 only (appetite, acne, and food cravings, p = 0.027). The secondary end points, Beck Depression Inventory (BDI) and Profile of Mood States (PMS), were consistent with the primary end point in that patients treated with the oral contraceptive showed a numerically greater improvement from baseline compared with those treated with placebo. The results of this study show a consistent trend in the reduction of symptoms that suggested a beneficial effect of DRSP/EE for the treatment of PMDD, despite limitations of the study design.     

An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome

BackgroundThis article presents an overview of four studies that evaluated a continuous oral contraceptive (OC) containing levonorgestrel (90 mcg) and ethinyl estradiol (20 mcg; LNG/EE) for managing premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS).Study DesignThree randomized, double-blind, placebo-controlled trials and one open-label, single-treatment substudy examined mean changes from baseline in the Daily Record of Severity of Problems (DRSP) or Penn Daily Symptom Rating (DSR).ResultsImprovements from baseline in mean DRSP and DSR scores were observed, but results were not consistent among the studies. Mean percent improvement of premenstrual symptoms ranged from 30% to 59% in controlled trials and 56% to 81% in an open-label substudy. A large placebo effect was also observed in the placebo-controlled studies. Continuous LNG/EE yielded a favorable safety profile.ConclusionsThese data, although not consistent, indicate that continuous LNG/EE may reduce the symptoms of PMDD and PMS, providing an option for women who are appropriate candidates for a continuous OC as a contraceptive, the approved indication for this medication.     

Gender specific alterations of body composition in patients with inflammatory bowel disease compared with controls.

OBJECTIVE: To assess body hydration and the distribution of the body water compartments in defined populations of patients with inflammatory bowel disease (IBD) compared with those of matched healthy controls. SUBJECTS: Fifty-two patients with IBD at time of diagnosis (20 patients with Crohn's disease (CD-new) and 32 patients with ulcerative colitis (UC-new)), 40 patients with long-standing CD (CD-long) and 2 matched healthy control groups (n = 52 and n = 40) were recruited for the study. METHODS: Total body water (TBW) and extracellular water (ECW) were measured by deuterium oxide and bromide dilution, respectively. Intracellular water (ICW) was calculated as TBW-ECW. In addition, hydration of fat-free mass (FFM) and the ECW:ICW ratio were calculated. FFM, body fat (BF) and % body fat (%BF) were assessed by dual energy X-ray absorptiometry. RESULTS: In female IBD patients, the ECW:ICW ratio was significantly (P < 0.05) higher than in controls (CD-new: 0.89+/-0.11 vs 0.79+/-0.08, P < 0.01; UC-new: 0.85+/-0.15 vs 0.77+/-0.10, P < 0.05; CD-long: 0.86+/-0.14 vs 0.80+/-0.10, P < 0.05). In these female patients, the ICW:FFM ratio was significantly (P < 0.05) lower than in controls. Fluid shifts were especially pronounced in female patients with recently diagnosed CD. In male patients with recently diagnosed UC and in those with long-standing CD, body weight, body mass index, BF and %BF were significantly (P < 0.05) lower than in controls. No differences in body hydration or body water distribution were observed between male patients and controls. CONCLUSIONS: An altered body water distribution and body hydration was observed in female IBD patients, especially in female patients with recently diagnosed CD.     

Body composition in patients with an ileostomy and inflammatory bowel disease: validation of bio-electric impedance spectroscopy (BIS)

OBJECTIVE: To validate bio-electric impedance spectroscopy (BIS) by comparison with other methods for determination of body water compartments in stable subjects with an ileostomy and no or minor small bowel resection for inflammatory bowel disease (IBD). SUBJECTS: Twenty-one subjects were included, age range 36-65 y (female/male=12/9), Crohn's disease (CD), n=14, ulcerative colitis (UC), n=6 and indeterminate colitis (IDC), n=1. METHODS: Fluid compartments were assessed by the use of three independent methods: BIS, dual-energy X-ray absorptiometry (DXA) and dilution techniques (DIL); tritiated water (total body water, TBW); and bromide (extracellular water, ECW), respectively. Intra-cellular water (ICW) was calculated as TBW-ECW. For comparison TBW was also predicted according to an empirical formula. Differences were analysed using Bland-Altman plots. RESULTS: The mean TBW values obtained from the impedance measurement differed in the order of -2.21 (DIL) to 1.41 (DXA) in women and -2.01 (DIL) to 2.61 (DXA) in men, from the measured and derived values of total body water. Prediction of TBW gave values that were close to BIS, with a mean difference of -0.31 in male subjects and +0.51 in female subjects.Assessment of ECW revealed that the mean difference between dilution and impedance was less in women than in men (P<0.01). CONCLUSION: The differences between all methods to assess fluid compartments are pronounced. To further investigate the use of the method in clinical practice for dynamic monitoring of rehydration in ileostomates with acute diarrhoea, repeated measurements together with comparison with weight fluid-balance charts are suggested. SPONSORSHIP: The study was supported by grants from the Swedish Medical Research Council (17X-03117), G?teborgs L?kars?llskap and IB and A Lundbergs forskningsstiftelse.     

Is resting metabolic rate different between men and women?

A low resting metabolic rate (RMR) has been proposed as a possible cause for the increased body fat commonly seen in women compared with men. Absolute RMR is higher in men, but whether RMR adjusted for lean body mass (LBM) remains higher is unresolved. The objective of the present study was to determine whether RMR adjusted for various body composition factors differed between healthy adult men and women. Thirty men years, BMI and twenty-eight women years, BMI were included in the analyses. RMR was measured by open-circuit indirect calorimetry for 60 min. Extracellular water (ECW) was measured by corrected Br(-) space and total body water (TBW) by 2H dilution. LBM was estimated as TBW/0.732. Intracellular water (ICW) was calculated as TBW-ECW, and body cell mass (BCM) as ICW/0.732. Men were heavier and had higher BMI, LBM, BCM and ECW, but less fat mass. Absolute RMR was higher in men than women v. P<0.0001). This difference became non-significant when RMR was adjusted for LBM by ANCOVA v. P=0.2191), but remained significant when adjusted for BCM v. P=0.0249). Fat mass explained a significant amount of variation in RMR in women (r(2) 0.28, P=0.0038), but not in men (r(2) 0.03, P=0.3301). The relationships between body fat and the various subcompartments of BCM and RMR require further elucidation.     

Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment.

BACKGROUND: Triple antiretroviral treatment including protease inhibitors (PIs) delays the clinical progression of HIV infection and may thus reduce the risk of malnutrition. However, fat redistribution (lipodystrophy) was recognized recently as a metabolic side effect of PIs. OBJECTIVE: The study aimed to assess the effect of triple antiretroviral treatment on body composition and on the prevalence of malnutrition. DESIGN: Two cross-sectional studies, 1 in 1996 (t96; n = 247) and 1 in 1997 (t97; n = 266), were conducted in HIV-infected outpatients. Among patients who participated in both studies, 111 patients started a new antiretroviral treatment including a PI between t96 and t97 and were studied longitudinally. Total body water (TBW), intracellular water (ICW), extracellular water (ECW), and fat mass were estimated by monofrequency bioelectrical impedance analysis (BIA). RESULTS: Prevalence of malnutrition was reduced by 30-50% from t96 to t97, depending on the definition used. In the longitudinal study, TBW and the ratio between ICW and ECW increased and fat mass decreased (P < 0.001). BIA indicated a greater increase in ICW in 23 (21%) patients with clinically apparent fat redistribution than in patients without this syndrome, but estimates of fat mass changes were not significantly different. CONCLUSIONS: Triple antiretroviral treatment may protect HIV-infected patients against the development of malnutrition. Whole-body BIA data suggest an increase in appendicular body cell mass associated with improved antiretroviral treatment. However, the method is unreliable in detecting fat redistribution, and current prediction equations will need to be recalibrated for HIV-infected patients receiving highly active antiretroviral treatment.     

A whole-body model to distinguish excess fluid from the hydration of major body tissues

BACKGROUND: Excess fluid (ExF) accumulates in the body in many conditions. Currently, there is no consensus regarding methods that adequately distinguish ExF from fat-free mass. OBJECTIVE: The aim was to develop a model to determine fixed hydration constants of primary body tissues enabling ExF to be calculated from whole-body measurements of weight, intracellular water (ICWWB), and extracellular water (ECWWB). DESIGN: Total body water (TBW) and ECWWB were determined in 104 healthy subjects by using deuterium and NaBr dilution techniques, respectively. Body fat was estimated by using a reference 4-component model, dual-energy X-ray absorptiometry, and air-displacement plethysmography. The model considered 3 compartments: normally hydrated lean tissue (NH_LT), normally hydrated adipose tissue (NH_AT), and ExF. Hydration fractions (HF) of NH_LT and NH_AT were obtained assuming zero ExF within the diverse healthy population studied. RESULTS: The HF of NH_LT mass was 0.703 +/- 0.009 with an ECW component of 0.266 +/- 0.007. The HF of NH_AT mass was 0.197 +/- 0.042 with an ECW component of 0.127 +/- 0.015. The ratio of ECW to ICW in NH_LT was 0.63 compared with 1.88 in NH_AT. ExF can be estimated with a precision of 0.5 kg. CONCLUSIONS: To calculate ExF over a wide range of body compositions, it is important that the model takes into account the different ratios of ECW to ICW in NH_LT and NH_AT. This eliminates the need for adult age and sex inputs into the model presented. Quantification of ExF will be beneficial in the guidance of treatment strategies to control ExF in the clinical setting.     

腹部手术后体液含量与分布的变化及其影响因素

目的 :观察腹部手术后体液含量与分布变化,探讨其变化规律和影响因素。方法 :选择2016年3至6月入住我科的61例病人,利用人体成分分析仪,检测病人术前1天和术后第1、3、5、7天细胞内液(ICW)、细胞外液(ECW)、总体液(TBW)的含量,并依据年龄、性别、手术种类、手术时间、液体净入量分组,分析影响病人体液变化的因素。结果 :与术前1天相比,术后第1天病人ICW、ECW、TBW明显增加(P0.05),且以ECW增加为主,并于术后第3至7天降至术前水平。不同种类手术病人术后第1天体液净增加量不同,女性较男性体液增加多,并且术后第1天体液净增加量与手术时间、液体净入量呈正相关。结论 :腹部手术后早期病人存在体液潴留现象,以ECW潴留为主;手术时间延长、液体净入量增加是术后病人体液潴留的主要影响因素。     

Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis

OBJECTIVE: To measure body water distribution and to evaluate the accuracy of eight-polar bioelectrical impedance analysis (BIA) for the assessment of total body water (TBW) and extracellular water (ECW) in severe obesity. DESIGN: Cross-sectional study. SETTING: Obesity clinic. SUBJECTS: In all, 75 women aged 18-66 y, 25 with body mass index (BMI) between 19.1 and 29.9 kg/m(2) (ie not obese), 25 with BMI between 30.0 and 39.9 kg/m(2) (ie class I and II obese), and 25 with BMI between 40.0 and 48.2 kg/m(2) (ie class III obese). METHODS: TBW and ECW were measured by (2)H(2)O and Br dilution. Body resistance (R) was obtained by summing the resistances of arms, trunk and legs as measured by eight-polar BIA (InBody 3.0, Biospace, Seoul, Korea). The resistance index at a frequency of x kHz (RI(x)) was calculated as height (2)/R(x). RESULTS: ECW : TBW was similar in women with class III (46+/-3%, mean+/-s.d.) and class I-II obesity (45+/-3%) but higher than in nonobese women (39+/-3%, P<0.05). In a random subsample of 37 subjects, RI(500) explained 82% of TBW variance (P<0.0001) and cross-validation of the obtained algorithm in the remaining 38 subjects gave a percent root mean square error (RMSE%) of 5% and a pure error (PE) of 2.1 l. In the same subjects, RI(5) explained 87% of ECW variance (P<0.0001) and cross-validation of the obtained algorithm gave a RMSE% of 8% and a PE of 1.4 l. The contribution of weight and BMI to the prediction of TBW and ECW was nil or negligible on practical grounds. CONCLUSIONS: ECW : TBW is similar in women with class I-II and class III obesity up to BMI values of 48.2 kg/m(2). Eight-polar BIA offers accurate estimates of TBW and ECW in women with a wide range of BMI (19.1-48.2 kg/m(2)) without the need of population-specific formulae.     

Suitability of Bioelectrical Based Methods to Assess Water Compartments in Recreational and Elite Athletes

Objective: It is important for highly active individuals to easily and accurately assess their hydration level. Bioelectrical impedance (BIA) can potentially meet these needs but its validity in active individuals is not well established. We aim to validate total body water (TBW), extracellular water (ECW), and intracellular water (ICW) estimates obtained from 50 kHz BIA, bioelectrical impedance spectroscopy (BIS), and BIA-based models against dilution techniques in 2 populations: active adults and elite athletes.

Methods: Active males (N = 28, 20–39 years) involved in recreational sports and elite athletes (females: N = 57, 16–35 years; males: N = 127, 16–38 years) participated in this study. TBW and ECW were assessed with deuterium and bromide dilution, respectively. ICW was assessed as their difference. Body water compartments were also assessed by BIA (BIA-101), BIS (model 4200), and BIA-based equations.

Results: Small but significant differences were observed between alternative methods and the criterion in all subsamples. In female athletes, r² > 0.69, r² > 0.57, and r² > 0.65 were observed between methods in the TBW, ECW, and ICW estimates. In males, r² > 0.75, r² > 0.65, and r² > 0.68 were found between alternative and reference methods in the TBW, ECW, and ICW estimates, respectively, whereas for male recreational exercisers, r² > 0.58, r² > 0.73, and r² > 0.75 were observed. Pure errors ranged between 0.19 to 3.32 kg for TBW, 0.64 to 1.63 for ECW, and 1.98 to 2.64 in ICW. The highest limits of agreement (LoA) were observed in Van Loan and Mayclin equation and the BIA method, respectively, for TBW and ECW assessment and the lowest LoA were observed in BIS for both TBW and ECW estimates.

Conclusions: The higher accuracy of BIS in predicting individual TBW, ECW, and ICW highlights its utility in water assessment of recreational and elite athletes.     

Loss of total body water and extracellular water assessed by multifrequency impedance.

Fat-free mass (FFM), total body water (TBW), extracellular water (ECW) and bioelectrical impedance at 15 selected frequencies, ranging from 1 kHz to 1350 kHz, were determined in 12 subjects before and 3 h after the use of a diuretic drug to induce loss of ECW. Weight loss and urine loss were recorded, and these were assumed to be equal to loss of FFM and TBW, respectively. From the excretion of sodium the amount of excreted ECW was calculated. Prediction formulae at all frequencies were developed for FFM, TBW and ECW from impedance data before the use of the diuretic drug. With these formulae the changes in FFM, TBW and ECW were predicted and compared with the losses of body weight, urine and ECW. At all frequencies FFM, TBW and ECW could be well predicted, with comparable values of explained variance and standard errors of estimate. However, the losses in FFM and TBW were significantly overestimated using the low-frequency impedance formulae. At higher frequencies the predicted losses were no longer significantly different from the weight and urine losses, respectively. The change in ECW was only adequately predicted at 1 kHz. Prediction formulae for ECW at higher frequencies underestimated the loss of ECW. It is concluded that multifrequency impedance offers the possibility of distinguishing between body fluid compartments and of assessing changes in body fluid compartments with a reasonable error.     

An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women

This study was conducted to compare the cycle control, efficacy and adverse events of a new low-dose oral contraceptive pill regimen containing 3 mg drospirenone (DRSP)/30 microg ethinylestradiol (EE), with a widely prescribed 150 microg levonogestrel (LNG)/30 microg EE. The results of this comparative trial demonstrated that the two preparations had no statistically significant difference in terms of cycle control, efficacy and adverse events. The occurrence of spotting and breakthrough bleeding was low and was not different between the two regimens. There was neither amenorrhea nor pregnancies reported in either group. The most common adverse events in both groups were nausea, headache and breast tenderness. Also statistically significant changes were found in body weight and blood pressure in both groups at the end of the study. In conclusion, the 3 mg DRSP/30 microg EE regimen provides good cycle control with reliable contraceptive efficacy and a low incidence of adverse events equal to the 150 microg LNG/30 microg EE preparation. Compared with the 150 microg LNG/30 microg EE preparation, the 3 mg DRSP/30 microg EE preparation demonstrated a more favorable effect on body weight and blood pressure, with the mean body weight and mean blood pressure remaining lower than baseline mean. The new formulation may be especially beneficial for women susceptible to body weight gain and rise in blood pressure.     

腹膜透析病人体内水分布与营养状况的关系

目的:了解持续性不卧床腹膜透析(CAPD)病人体内水的分布状况及其与营养之间的关系。方法:用生物电阻抗法对66名无临床水肿表现的CAPD病人进行体内水的测量,分别测出其细胞外液(ECW)、细胞内液(ICW)、总体水(TBW),同时对所有病人进行营养状况的主观综合评价(SGA)。相同年龄段的正常人作为对照。结果:临床无水肿的CAPD病人与相同年龄的正常人相比,体内水的分布存在明显异常,表现为细胞内液显著减少,细胞外液无明显变化,细胞外液与细胞内液之比(E/I)明显增加;当病人存在营养不良时,上述现象表现得更加明显。结论:持续性不卧床式腹膜透析(CAPD)病人体内水的分布是异常的,营养不良可以加重体内水的异常分布。因此,对于临床无明显水肿表现但存在营养不良的CAPD病人不能通过E/I来判断体内是否存在水负荷过多。     

Maternal nutritional status in early pregnancy is associated with body water and plasma volume changes in a pregnancy cohort in rural Bangladesh

Plasma volume expansion has been associated with fetal growth. Our objective was to examine the associations between maternal nutritional status in early pregnancy and extracellular water (ECW), total body water (TBW), and percentage plasma volume change across pregnancy. In a subsample of 377 pregnant women participating in a cluster-randomized trial of micronutrient supplementation, hemoglobin, hematocrit, and multi-frequency bioelectrical impedance were measured at ~10, 20, and 32 wk of gestation. In early pregnancy, women were short (mean ± SD, 148.9 ± 5.3 cm) and thin (19.5 ± 2.5 kg/m(2)). In mixed-effects multiple regression models, a 1-unit higher BMI at ~10 wk was associated with higher ECW and TBW (0.27 and 0.66 kg per kg/m(2), respectively; P < 0.01) at ~10, ~20, and ~32 wk. Height was also positively associated with ECW and TBW at each time point. Early pregnancy BMI was negatively associated with gains in ECW and TBW (-0.06 and -0.14 kg per kg/m(2), respectively; P < 0.01) from 10 to 20 wk, but not with 20- to 32-wk gains after accounting for weight gain. BMI was positively associated with percentage changes in plasma volume from 20 to 32 wk (0.57% per kg/m(2); P < 0.05). Height was not associated with changes in body water or plasma volume. Women with low BMI and height in early pregnancy have lower ECW and TBW in early, mid, and late pregnancy and lower late pregnancy plasma volume expansion, potentially increasing risk of fetal growth restriction.